Adverse Drug Reactions

Dr. Shubham Sewariya is a Research Scientist at the University of Delhi, India, with expertise in medicinal chemistry and drug discovery. His research focuses on developing novel anticancer drug leads by combining synthetic chemistry, biological insights, and computational approaches. He holds an Integrated BS–MS degree in Chemistry from the Indian Institute of Science Education and Research (IISER), Thiruvananthapuram, and has completed his Ph.D. jointly at University of Delhi and the University of Lancashire, UK. His doctoral work centers on the discovery and development of secondary metabolites, including noscapinoids and coumarins, as potential anticancer agents. Dr. Sewariya has received several prestigious fellowships and awards, including the Commonwealth Split-site PhD Scholarship (2023–24) funded by the UK Foreign, Commonwealth & Development Office, the CSIR Senior Research Fellowship, and the INSPIRE SHE Fellowship from Department of Science and Technology, Govt of India. He has also presented his work at international platforms such as the American Chemical Society (ACS) conferences in San Francisco and Chicago. With more than a dozen peer-reviewed publications, his contributions span synthetic chemistry, nanomedicine, and biophysical studies, particularly in designing intelligent nanocarriers and molecular probes for cancer therapy. Beyond the laboratory, Dr. Sewariya is deeply committed to advancing translational research that bridges science and medicine for the betterment of human health.